08/03/2023
6:10 AM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:16 AM | Kymera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/20/2023
4:55 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Kymera Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Hrustanovic Gorjan (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Esposito Pamela (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Albers Jeffrey W. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Horobin Joanna (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/20/2023
3:15 PM | Booth Bruce (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Kymera Therapeutics (Issuer)
Ridloff Elena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Kymera Therapeutics (Issuer)
MARAGANORE JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Kymera Therapeutics (Issuer)
Morgan Leigh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:16 PM | Kymera Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
1:17 PM | Jacobs Bruce N. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
6:28 PM | Chadwick Jeremy G (Reporting)
Kymera Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2023
6:35 PM | Chadwick Jeremy G (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
3:45 PM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:10 AM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:16 AM | Kymera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/10/2023
4:30 PM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2023
3:30 PM | Jacobs Bruce N. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2023
3:30 PM | Gollob Jared (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2023
3:31 PM | Kymera Therapeutics (Issuer)
Mainolfi Nello (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2023
4:22 PM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2023
6:31 AM | Kymera Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/23/2023
6:11 AM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2023
6:16 AM | Kymera Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2023
3:28 PM | Atlas Venture Fund X, L.P. (Filed by)
Kymera Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2023
8:37 AM | Avoro Capital Advisors LLC (Filed by)
Kymera Therapeutics (Subject)
| Form SC 13G | |
02/08/2023
1:16 PM | Kymera Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
02/06/2023
2:02 PM | Kymera Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/13/2023
4:08 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Kymera Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2023
3:50 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2023
3:53 PM | Booth Bruce (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2023
6:06 AM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2023
3:35 PM | Chiniara Ellen (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2022
4:03 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2022
4:05 PM | Booth Bruce (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2022
8:27 AM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2022
6:16 AM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2022
5:11 PM | Kymera Therapeutics (Issuer)
Mainolfi Nello (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2022
3:30 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/04/2022
3:31 PM | Booth Bruce (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2022
6:19 PM | Kymera Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/03/2022
6:22 PM | Kymera Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2022
6:17 AM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2022
6:20 AM | Kymera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2022
6:34 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
6:36 PM | Booth Bruce (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2022
7:00 AM | Jacobs Bruce N. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2022
7:09 PM | Kymera Therapeutics (Issuer)
Mainolfi Nello (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2022
7:12 PM | Jacobs Bruce N. (Reporting)
Kymera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2022
3:36 PM | Kymera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
